Improving the Quality of Care of Osteoporosis in the Elderly |
Certified
for 1 AMA PRA Category 1 Credit™
Co-Sponsored
by
the
University of Alabama
School
of Medicine
Division of Continuing Medical Education,
Division of Gerontology, Geriatrics, and
Palliative Care, and
The Center for Aging
| Release
Date: November 6, 2007 |
Expiration
Date: November 6, 2010 |
| TARGET
AUDIENCE: |
| Primary
care physicians |
| OBJECTIVES: |
| Upon
completion of this CME activity,
physicians and other healthcare professionals
should be able to: |
- Identify appropriate circumstances for screening and treatment of osteoporosis in older patients.
- Recognize gender and racial disparities in the treatment and prevention of osteoporosis.
- Evaluate current barriers to osteoporosis quality of care and review recent quality improvement initiatives that address these barriers.
|
| Top of Page |
| SOURCE: |
| EDITOR
AND CONTRIBUTING AUTHORS: |
Angela
R. Curtis, PhD
Managing Editor
Assistant Professor, Geriatric Education
Manager
Division
of Gerontology, Geriatrics and
Palliative Care
Amy Warriner , MD
Assistant Professor
Division of Endocrinology and Metabolism
Jeffrey R. Curtis, MD, MPH
Assistant Professor
Division of Clinical Immunology and Rheumatology
University of Alabama at Birmingham
Birmingham, Alabama |
| Top of Page |
| |
| DISCLOSURE: |
The
faculty has the following commercial affiliations
to disclose:
Dr. Curtis: Grants/research support from Proctor & Gamble Pharmaceuticals, Novartis, Merck, and Lilly; Consultant with Roche; and Honorarium from Roche, Merck, Proctor & Gamble Pharmaceuticals, Lilly, and Novartis.
Dr. Warriner: Grants/research support from Proctor & Gamble Pharmaceuticals.
Dr. Curtis has no commercial affiliations to disclose.
Because of the nature of preliminary
studies, some products mentioned are
unlabeled and investigational. Dosages,
indications, and methods of use of
drugs mentioned in this publication
may reflect the experience of the authors,
clinical literature, or other resources.
Therefore, please see the full prescribing
information before using any licensed
product mentioned. |
| CME
PARTICIPATION: |
| To
participate in this online course
for CME credit, please review the
objectives before beginning the program.
Complete the course and the self-assessment
test before November 6, 2010 to receive
CME credit. Your certificate will
then be available online. This process
should take approximately 1 hour. |
| ACCREDITATION: |
The
University of Alabama School of
Medicine is accredited by the Accreditation
Council for Continuing Medical
Education to provide continuing
medical education for physicians.
The
University of Alabama School of
Medicine designates this educational
activity for a maximum of 1 AMA
PRA Category 1 Credit™.
Physicians should only claim credit
commensurate with the extent of
their participation in the activity.
The
boards of nursing in many states,
including Alabama, recognize Category
1 continuing medical education
courses as acceptable activities
for the renewal of license to practice
nursing. |
| DISCLAIMER: |
| Dosages,
indications, and methods of use of
any drug referred to in this publication
may reflect the clinical experience
of the authors, clinical literature,
or other clinical resources. Therefore,
please see the full prescribing information
before using any product mentioned.
UAB is an equal opportunity/affirmative
action institution. |
| INTRODUCTION: |
Osteoporosis detection and prevention are frequently overlooked by providers, in part related to the numerous other chronic illnesses for which these patients are concurrently treated. Patients are also rarely aware of underlying osteoporosis because this disease is typically silent until a fracture occurs. However, the morbidity, mortality, and health care costs associated with osteoporosis and fragility fractures are rising significantly as the U.S. population ages. Therefore, efforts are being made to improve the disconnect between current clinical evidence and widespread underdiagnosis and undertreatment in the field of osteoporosis. |
| CASE 1: |
Mrs. G is a 73-year-old white woman with a history of high blood pressure and breast cancer treated with radical mastectomy and external beam radiation 5 years ago with no evidence of residual disease. She is currently taking lisinopril for her hypertension and a daily multivitamin. She has recently moved to the area and is presenting for initial evaluation. She was followed previously by an internist who maintained all of her screening and preventative care including a bone mineral density (BMD) test three years ago. Her BMD at that time showed evidence of osteopenia with a T-score at her L1-L4 spine 1.5 standard deviations below the normal (i.e., T-score = -1.5). She was told at that time that no treatment was necessary.
|
|
